We are happy to share that, starting next year, we will work on yet another mitochondrial synthetic lethality-related project.
18 Nov 2025
What is better for celebration than a cake? And we have so much to celebrate! Our new project, Drug repurposing for the therapy of MYC-driven pediatric tumors via mitochondrial synthetic lethality, was supported by AZV and will run for four years. This also gives us the pleasant obligation to search for a new PhD student who will join us to work on this topic.